Clinical commercialization of a clonal cell line - NK92

被引:0
|
作者
Keller, G
Klingemann, H
Tonn, T
LeFever, A
Borys, M
Palazzolo, M
Domanik, R
机构
[1] ZelleRx Corp, Chicago, IL USA
[2] St Lukes Med Ctr, Dept Immunotherapy, Aurora Healthcare, Milwaukee, WI USA
[3] Abbott Labs, Specialty Prod Div, N Chicago, IL 60064 USA
[4] Inst Transfus Med & Hematol, Red Cross Blood Donor Serv, Frankfurt, Germany
[5] IIT, Stuart Grad Sch Business, Chicago, IL 60616 USA
来源
JOURNAL OF IMMUNOTHERAPY | 2003年 / 26卷 / 06期
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:S20 / S20
页数:1
相关论文
共 50 条
  • [21] Detection of Active Granzyme A in NK92 Cells with Fluorescent Activity-Based Probe
    Kolt, Sonia
    Janiszewski, Tomasz
    Kaiserman, Dion
    Modrzycka, Sylwia
    Snipas, Scott J.
    Salvesen, Guy
    Drag, Marcin
    Bird, Phillip, I
    Kasperkiewicz, Paulina
    JOURNAL OF MEDICINAL CHEMISTRY, 2020, 63 (06) : 3359 - 3369
  • [22] Successful expansion and cryopreservation of human natural killer cell line NK-92 for clinical manufacturing
    Lee, Seul
    Joo, Yunjoo
    Lee, Eun Ji
    Byeon, Youngseon
    Kim, Jae-Hwan
    Pyo, Kyoung-Ho
    Kim, Young Seob
    Lim, Sun Min
    Kilbride, Peter
    Iyer, Rohin K.
    Li, Mingming
    French, Mandy C.
    Lee, Jung-Yub
    Kang, Jeeheon
    Byun, Hyesin
    Cho, Byoung Chul
    PLOS ONE, 2024, 19 (02):
  • [23] Delivering mRNA to a human NK cell line, NK-92 cells, by lipid nanoparticles
    Nakamura, Takashi
    Nakade, Taisei
    Sato, Yusuke
    Harashima, Hideyoshi
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2023, 636
  • [24] 重组腺相关病毒对NK92细胞的转导条件优化
    沈晓丽
    周群刚
    郑然
    沈湘君
    邱香
    李泰明
    中国药科大学学报, 2023, 54 (01) : 115 - 121
  • [25] Inhibition of the activating signals in NK92 cells by recombinant GST-sHLAG1α chain
    Ai Yu YAO~(1
    CellResearch, 2004, (02) : 155 - 160
  • [26] Study of the human clonal cell line NK-92 cytolytic ability in patients with non-small cell lung cancer and evaluation of the role of chemotherapy
    Tsartsalis, D.
    Skopeliti, M.
    Dragioti, E.
    Tsartsalis, A.
    Tsitsilonis, O.
    Syrigos, K.
    LUNG CANCER, 2007, 55 : S6 - S6
  • [27] Molecular cytogenetic analysis of a natural killer cell line (NK-92).
    Nagel, S
    MacLeod, RAF
    Kaufmann, M
    Drexler, HG
    BLOOD, 2001, 98 (11) : 153B - 153B
  • [28] Efficient delivery of oncolytic enterovirus by carrier cell line NK-92
    Podshivalova, Elizaveta Sergeevna
    Semkina, Alevtina Sergeevna
    Kravchenko, Dmitry Sergeevich
    Frolova, Elena Ivanovna
    Chumakov, Stepan Petrovich
    MOLECULAR THERAPY-ONCOLYTICS, 2021, 21 : 110 - 118
  • [29] Development of myeloma-specific NK-92 cell line variants
    Yang, S
    An, X
    Brown, RD
    Ho, J
    Gibson, J
    Joshua, DE
    Wels, W
    Sze, DM
    TISSUE ANTIGENS, 2005, 66 (05): : 596 - 596
  • [30] 氧分压变化对NK92细胞生存及黏附性的影响
    曲迅
    杨美香
    梁璐
    宋海波
    杨咏梅
    邵倩倩
    刘佳
    高文娟
    龚非力
    中国免疫学杂志, 2007, (04) : 306 - 309